Benjamin Ungar
Icahn School of Medicine at Mount Sinai
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Benjamin Ungar as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:51 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07508488 · Deucravacitinib in the Treatment of Cicatricial AlopeciasIcahn School of Medicine at Mount Sinai · recruiting · Central Centrifugal Cicatricial Alopecia, Frontal Fibrosing Alopecia · principal investigator
- Ph2NCT07487948 · Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen PlanopilarisIcahn School of Medicine at Mount Sinai · recruiting · Central Centrifugal Cicatricial Alopecia, Lichen Planopilaris · principal investigator
- Ph2NCT06532136 · Deucravacitinib RosaceaIcahn School of Medicine at Mount Sinai · withdrawn · Papulopustular Rosacea · principal investigator
- Ph2NCT06013371 · PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular RosaceaIcahn School of Medicine at Mount Sinai · terminated · Seborrheic Dermatitis, Papulopustular Rosacea · principal investigator
- Ph2NCT05787860 · Ruxolitinib in Seborrheic DermatitisIcahn School of Medicine at Mount Sinai · completed · Seborrheic Dermatitis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:51 UTC. The ranking covers the 200 most relevant of 10 PubMed records, and a shared surname and initials can bring in a namesake. All 10 on PubMed
- Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.J Allergy Clin Immunol · 2019576 citationsRCR 29.1
- A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis.J Invest Dermatol · 201995 citationsRCR 4.9
- Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis.J Allergy Clin Immunol · 202190 citationsRCR 6.3
- Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled Trial.Clin Gastroenterol Hepatol · 202461 citationsRCR 12.0
- Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis.J Allergy Clin Immunol · 201758 citationsRCR 2.8
- A novel PillCam Crohn's capsule score (Eliakim score) for quantification of mucosal inflammation in Crohn's disease.United European Gastroenterol J · 202050 citationsRCR 3.8
- A phase 2a trial of brepocitinib for cicatricial alopecia.J Am Acad Dermatol · 202522 citationsRCR 11.3
- Capsule Endoscopy-Guided Proactive Treat-to-Target Versus Continued Standard Care in Patients With Quiescent Crohn's Disease: A Randomized Controlled Trial.Gastroenterology · 202522 citationsRCR 7.8
- Safety, efficacy and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti-tumour necrosis factor.Aliment Pharmacol Ther · 201815 citationsRCR 0.6
- The Visibility and Performance of Small Bowel Video Capsule Endoscopy With and Without Pre-Procedural Purge Preparation in the Same Patients.J Gastroenterol Hepatol · 20255 citationsRCR 3.2